Just diagnosed with Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate hub →Overview
Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate is a rare condition. Also known as Acute reversible leukoencephalopathy due to SLC13A3 deficiency, Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:615964 · OMIM 618384 · ICD-10 E75.2 · GARD 0018035
Find care for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
- Find a specialist or center for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
- Search recruiting clinical trials for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
- Open the interactive Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate hub — care near you, live trials & community
Authoritative references for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
Research & market landscape for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
Following Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate — the real-world landscape behind the condition, in one place.
- Latest Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate research on PubMed ↗
- Recruiting Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate trials on ClinicalTrials.gov ↗
- Explore the Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate and every rare condition. See how Tomeko works with industry →
Common questions
What is Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate?
Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate is a rare condition. Also known as Acute reversible leukoencephalopathy due to SLC13A3 deficiency, Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate together in one place.
What are the symptoms of Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate?
Symptoms of Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate.
How is Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate treated?
Treatment for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, and review current options with them.
What causes Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate — is it genetic?
The cause and inheritance of Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate can explain what it means for you and your family.
I was just diagnosed with Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate, filtered to your area.
Are there clinical trials for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate?
Tomeko shows live, recruiting studies for Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3
